VIR compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

VIRVir Biotechnology, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

VIRVir Biotechnology, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

VIR

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±11.7%▼−6.37%×0.55

Q2 FY26±11.6%▼−3.79%×0.33

Q1 FY26±13.9%▼−9.91%×0.71

Feb 24 '26±26.6%▲+27.73%×1.04

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.7%▲+3.73%×1.00

Q2 FY26±4.1%▲+4.57%×1.12

= impliedVIR realized, solidAMGN realized, hatchedOne scale, both sides: full bar = 28%× = |realized| ÷ impliedSource: market data

Q1 FY26

±3.9%

▼−4.75%

×1.23

Feb 4 '26±3.7%▲+8.15%×2.22

VIRVir Biotechnology, Inc.

12.20▲+10.71%· post 12.30

Mkt cap$2.1BRevenue$239MQ2 FY26Revenue$74MFY24

AMGNAmgen Inc

460.55▲+0.06%· post 460.42

ClosedNov 6 '26

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

ClosedNov 6 '26

VIRVir Biotechnology, Inc.

AMGNAmgen Inc

12.20▲+10.71%post 12.30

Price

460.55▲+0.06%post 460.42

$2.1B

Mkt cap

$249.0B

Q2 FY26$239M

Revenue

$10.4BQ3 FY26

FY24$74M

Revenue

$36.8BFY25

VIR12.20▲+10.71%vsAMGN460.55▲+0.06%ClosedNov 6 '26